Skip to main content
Clinical Trials/NCT00080184
NCT00080184
Completed
Phase 1

Effectiveness of EEG Biofeedback in the Treatment of Fibromyalgia

National Center for Complementary and Integrative Health (NCCIH)1 site in 1 country40 target enrollmentDecember 2003
ConditionsFibromyalgia

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Enrollment
40
Locations
1
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.

Detailed Description

Fibromyalgia (FM) is a chronic disorder that involves chronic widespread musculoskeletal pain typically accompanied by fatigue, disordered sleep, cognitive complaints, psychological distress, and impairments in functioning. Treatments to date have been only partially effective and typically of modest benefit. Many persons with FM remain persistently dysfunctional and often disabled. This has given greater impetus for patients to seek complementary and alternative medicine (CAM) therapies. In this study, a variant of electroencephalograph (EEG) biofeedback known as Low Energy Neurofeedback System (LENS) will be used to reduce FM symptoms. Participants in this study will be randomly assigned to receive either LENS or placebo for several sessions. The Fibromyalgia Impact Questionnaire will be used to assess participants at the end of the study and at the 3- and 6- month follow-up visits.

Registry
clinicaltrials.gov
Start Date
December 2003
End Date
May 2006
Last Updated
19 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials